Skip to main content
NUTXNutex Health Inc.Buy Wait7.0·$179.55-4.44%
NUTX · Concentration risk · 10-K extracted

Nutex Health (NUTX) concentration risks

Updated

The most significant concentration Nutex Health discloses is HaloMD (exclusive IDR claims processor), classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Nutex Health’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 1 disclosed concentration

HIGH1
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partyCounterparty

HaloMD (exclusive IDR claims processor)

10-K Item 1A: 'Since May 2024, HaloMD has handled, on an exclusive basis, all out-of-network claims made by Nutex that are eligible for arbitration under federal and state “no surprise” laws.'
SEC 10-K · filed Mar 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-06

Nutex Health's disclosed concentration risk is narrow but consequential: since May 2024, HaloMD has handled, on an exclusive basis, all of Nutex's out-of-network claims eligible for arbitration under federal and state "no surprises" laws. This is a high, dependency-driven exposure — the company has routed its entire out-of-network claims-arbitration process through a single third-party processor, rather than spreading that function across multiple vendors or handling it internally. Because the arrangement is exclusive rather than one of several parallel relationships, any disruption to HaloMD's operations, performance, or the terms of that relationship would directly affect Nutex's ability to process and collect on out-of-network arbitration claims, with no alternative processor disclosed as a fallback. Given that this is the only concentration item disclosed in the sourced filing text, it stands as the single most relevant concentration factor for this company: a counterparty-specific dependency embedded in a regulatory process (no-surprises-act arbitration) that is itself relatively novel and still evolving, adding an additional layer of uncertainty beyond the concentration itself.

For the engine’s reasoning on NUTX’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Care Facilities

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
ACHCAcadia Healthcare Company, Inc.1102
NUTXNutex Health Inc.1001
ADUSAddus HomeCare Corporation0246
ARDTArdent Health, Inc.0202
AMNAMN Healthcare Services Inc0011
AGLagilon health, inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks NUTX Concentration risk